Health
New strategic collaboration to accelerate treatments for unmet medical needs in oncology – News-Medical.Net
The University of Texas MD Anderson Cancer Center and Taiho Pharmaceutical Co., Ltd., today announced a three-year strategic collaboration to accelerate the development of treatments for significant unmet medical needs in oncology, including patients with bra…
Reviewed by Emily Henderson, B.Sc.Sep 25 2020
The University of Texas MD Anderson Cancer Center and Taiho Pharmaceutical Co., Ltd., today announced a three-year strategic collaboration to accelerate the development of treatments for significant unmet medical needs in oncology, including patients with brain metastases and those with cancers refractory to available therapies.
This collaboration will bring Taiho’s unique portfolio of preclinical and clinical brain-penetrant therapies together wit…
-
Business24 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business23 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News20 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
General7 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A